Estrogen reduces lipid content in the liver exclusively from membrane receptor signaling

Science Signaling

Volumn 6, Issue 276, 2013, Pages

  Pedram, Ali ^a   Razandi, Mahnaz ^b   O'Mahony, Fiona ^a,b   Harvey, Harry ^c   Harvey, Brian J ^c   Levin, Ellis R ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^c ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,5 TRIS(4 HYDROXYPHENYL) 4 PROPYLPYRAZOLE; ADENOSINE PHOSPHATE; CHOLESTEROL; ESTROGEN RECEPTOR; LIVER EXTRACT; MEMBRANE RECEPTOR; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIACYLGLYCEROL;

ARTICLE; CELL MEMBRANE; CHOLESTEROL SYNTHESIS; CYTOPLASM; FATTY ACID ANALYSIS; GENE EXPRESSION; LIGAND BINDING; LIPOGENESIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TRANSGENIC MOUSE; WILD TYPE;

ADENYLATE KINASE; ANIMALS; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ESTROGEN RECEPTOR ALPHA; ESTROGENS; LIPIDS; LIVER; MICE; MICE, KNOCKOUT; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

MUS; MUS MUSCULUS;

EID: 84878331707     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004013     Document Type: Article

References (40)

1. E. V. Jensen, E. R. Desombre, T. Kawashima, T. Suzuki, K. Kyser, P. W. Jungblut, Estrogen binding substances of target tissues. Science 158, 529-530 ( 1967).
2. C. M. Szego, J. S. Davis, Adenosine 3′,5′-monophosphate in rat uterus: Acute elevation by estrogen. Proc. Natl. Acad. Sci. U.S.A. 58, 1711-1718 ( 1967).
3. L. Björnström, M. Sjöberg, Mechanisms of estrogen receptor signaling: Convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 19, 833-842 ( 2005).
4. S. R. Hammes, E. R. Levin, Extranuclear steroid receptors: Nature and function. Endocr. Rev. 28, 726-741 ( 2007).
5. A. Pedram, M. Razandi, J. K. Kim, F. O'Mahony, E. Y. Lee, U. Luderer, E. R. Levin, Developmental phenotype of a membrane only estrogen receptor α (MOER) mouse. J. Biol. Chem. 284, 3488-3495 ( 2009).
6. J. D. Horton, J. L. Goldstein, M. S. Brown, SREBPs: Activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 109, 1125-1131 ( 2002).
7. M. Zang, A. Zuccollo, X. Hou, D. Nagata, K. Walsh, H. Herscovitz, P. Brecher, N. P. Ruderman, R. A. Cohen, AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells. J. Biol. Chem. 279, 47898-47905 ( 2004).
8. K. A. Tobin, S. M. Ulven, G. U. Schuster, H. H. Steineger, S. M. Andresen, J. A. Gustafsson, H. I. Nebb, Liver X receptors as insulin-mediating factors in fatty acid and cholesterol biosynthesis. J. Biol. Chem. 277, 10691-10697 ( 2002).
9. N. Dif, V. Euthine, E. Gonnet, M. Laville, H. Vidal, E. Lefai, Insulin activates human sterol-regulatory-element-binding protein-1c (SREBP-1c) promoter through SRE motifs. Biochem. J. 400, 179-188 ( 2006).
10. B. D. Hegarty, A. Bobard, I. Hainault, P. Ferré, P. Bossard, F. Foufelle, Distinct roles of insulin and liver X receptor in the induction and cleavage of sterol regulatory element-binding protein-1c. Proc. Natl. Acad. Sci. U.S.A. 102, 791-796 ( 2005).
11. X. Deng, W. Zhang, I. O-Sullivan, J. B. Williams, Q. Dong, E. A. Park, R. Raghow, T. G. Unterman, M. B. Elam, FoxO1 inhibits sterol regulatory element-binding protein-1c (SREBP-1c) gene expression via transcription factors Sp1 and SREBP-1c. J. Biol. Chem. 287, 20132-20143 ( 2012).
12. H. Shimano, Sterol regulatory element-binding proteins (SREBPs): Transcriptional regulators of lipid synthetic genes. Prog. Lipid Res. 40, 439-452 ( 2001).
13. J. L. Goldstein, R. A. DeBose-Boyd, M. S. Brown, Protein sensors for membrane sterols. Cell 124, 35-46 ( 2006).
14. Y. Li, S. Xu, M. M. Mihaylova, B. Zheng, X. Hou, B. Jiang, O. Park, Z. Luo, E. Lefai, J. Y. J. Shyy, B. Gao, M. Wierzbicki, T. J. Verbeuren, R. J. Shaw, R. A. Cohen, M. Zang, AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin-resistant mice. Cell Metab. 13, 376-388 ( 2011).
15. A. Paquette, D. Wang, M. Jankowski, J. Gutkowska, J. M. Lavoie, Effects of ovariectomy on PPARα, SREBP-1c, and SCD-1 gene expression in the rat liver. Menopause 15, 1169-1175 ( 2008).
16. G. Bryzgalova, L. Lundholm, N. Portwood, J. A. Gustafsson, A. Khan, S. Efendic, K. Dahlman-Wright, Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice. Am. J. Physiol. Endocrinol. Metab. 295, E904- E912 ( 2008).
17. Z. Madak-Erdogan, M. Lupien, F. Stossi, M. Brown, B. S. Katzenellenbogen, Genomic collaboration of estrogen receptor a and extracellular signal-regulated kinase 2 in regulating gene and proliferation programs. Mol. Cell. Biol. 31, 226-236 ( 2011).
18. K. L. Chambliss, Q. Wu, S. Oltmann, E. S. Konaniah, M. Umetani, K. S. Korach, G. D. Thomas, C. Mineo, I. S. Yuhanna, S. H. Kim, Z. Madak-Erdogan, A. Maggi, S. P. Dineen, C. L. Roland, D. Y. Hui, R. A. Brekken, J. A. Katzenellenbogen, B. S. Katzenellenbogen, P. W. Shaul, Non-nuclear estrogen receptor a signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J. Clin. Invest. 120, 2319-2330 ( 2010).
19. A. Billon-Galés, C. Fontaine, C. Filipe, V. Douin-Echinard, M. J. Fouque, G. Flouriot, P. Gourdy, F. Lenfant, H. Laurell, A. Krust, P. Chambon, J. F. Arnal, The transactivating function 1 of estrogen receptor a is dispensable for the vasculoprotective actions of 17β-estradiol. Proc. Natl. Acad. Sci. U.S.A. 99, 2205-2210 ( 2009).
20. A. Billon-Galés, A. Krust, C. Fontaine, A. Abot, G. Flouriot, C. Toutain, H. Berges, A. P. Gadeau, F. Lenfant, P. Gourdy, P. Chambon, J. F. Arnal, Activation function 2 (AF2) of estrogen receptor-α is required for the atheroprotective action of estradiol but not to accelerate endothelial healing. Proc. Natl. Acad. Sci. U.S.A. 108, 13311-13316 ( 2011).
21. Z. Chen, I. S. Yuhanna, Z. Galcheva-Gargova, R. H. Karas, M. E. Mendelsohn, P. W. Shaul, Estrogen receptor α mediates the nongenomic activation of endothelial nitric oxide synthase by estrogen. J. Clin. Invest. 103, 401-406 ( 1999).
22. X. Guo, M. Razandi, A. Pedram, G. Kassab, E. R. Levin, Estrogen induces vascular wall dilation: Mediation through kinase signaling to nitric oxide and estrogen receptors α and β. J. Biol. Chem. 280, 19704-19710 ( 2005).
23. M. K. Bennett, Y. K. Seo, S. Datta, D. J. Shin, T. F. Osborne, Selective binding of sterol regulatory element-binding protein isoforms and co-regulatory proteins to promoters for lipid metabolic genes in liver. J. Biol. Chem. 283, 15628-15637 ( 2008).
24. G. Chen, G. Liang, J. Ou, J. L. Goldstein, M. S. Brown, Central role for liver X receptor in insulin-mediated activation of Srebp-1c transcription and stimulation of fatty acid synthesis in liver. Proc. Natl. Acad. Sci. U.S.A. 101, 11245-11250 ( 2004).
25. H. Shimano, SREBPs: Physiology and pathophysiology of the SREBP family. FEBS J. 276, 616-621 ( 2009).
26. D. Eberlé, B. Hegarty, P. Bossard, P. Ferré, F. Foufelle, SREBP transcription factors: Master regulators of lipid homeostasis. Biochimie 86, 839-848 ( 2004).
27. B. D. Reed, B. D. Charos, A. M. Szekely, S. M. Weissman, M. Snyder, Genome-wide occupancy of Srebf1 and its partners NFY and SP1 reveal novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet. 4, 31000133 ( 2008).
28. A. Pedram, M. Razandi, F. O'Mahony, D. Lubahn, E. R. Levin, Estrogen receptor b prevents cardiac fibrosis. Mol. Endocrinol. 24, 2152-2165 ( 2010).
29. A. Pedram, M. Razandi, E. R. Levin, Nature of functional estrogen receptors at the plasma membrane. Mol. Endocrinol. 20, 1996-2009 ( 2006).
30. M. H. Wyckoff, K. L. Chambliss, C. Mineo, I. S. Yuhanna, M. E. Mendelsohn, S. M. Mumby, P. W. Shaul, Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Gai. J. Biol. Chem. 276, 27071-27076 ( 2001).
31. P. Kumar, Q. Wu, K. L. Chambliss, I. S. Yuhanna, S. M. Mumby, C. Mineo, G. G. Tall, P. W. Shaul, Direct interactions with Gαi and Gβγ mediate nongenomic signaling by estrogen receptor a. Mol. Endocrinol. 21, 1370-1380 ( 2007).
32. i/o inhibition. Mol. Pharmacol. 80, 859-869 ( 2011).
33. 433, is essential for LKB1 to suppress cell growth. J. Biol. Chem. 276, 19469-19482 ( 2001).
34. T. M. D'Eon, S. C. Souza, M. Aronovitz, M. S. Obin, S. K. Fried, A. S. Greenberg, Estrogen regulation of adiposity and fuel partitioning: Evidence of genomic and non-genomic regulation of lipogenic and oxidative pathways. J. Biol. Chem. 280, 35983-35991 ( 2005).
35. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M. F. Hirshman, L. J. Goodyear, D. E. Moller, Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174 ( 2001).
36. J. L. Hawkins, M. D. Robbins, L. C. Warren, D. Xia, S. F. Petras, J. J. Valentine, A. H. Varghese, I. K. Wang, T. A. Subashi, L. D. Shelly, B. A. Hay, K. T. Landschulz, K. F. Geoghegan, H. J. Harwood Jr., Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. J. Pharmacol. Exp. Ther. 326, 801-808 ( 2008).
37. A. Pedram, M. Razandi, M. Aitkenhead, E. R. Levin, Estrogen inhibits cardiomyocyte hypertrophy in vitro: Antagonism of calcineurin-related hypertrophy through induction of MCIP1. J. Biol. Chem. 280, 26339-26348 ( 2005).
38. R Development Core Team, A Language and Environment for Statistical Computing ( R Foundation for Statistical Computing, Vienna, Austria, 2009).
39. D. W. Huang, B. T. Sherman, R. A. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57 ( 2009).
40. N. Gevry, K. Schoojans, F. Guay, B. D. Murphy, Cholesterol supply and SREBPs modulate transcription of the Niemann-Pick C-1 gene in steroidogenic tissues. J. Lipid Res. 49, 1024-1033 ( 2008).